Antioxidant properties of VKORC1L1

Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.

Hamostaseologie 2009; 29(S 01): S118-S119
DOI: 10.1055/s-0037-1621608

Communication

Schattauer GmbH

Antioxidative Eigenschaften der Vitamin-K- Epoxidoreduktase C1 L1

Autoren

P. Westhofen

¹Institute of Experimental Haematology and Transfusion Medicine, University Clinic Bonn, Germany
M. Watzka

¹Institute of Experimental Haematology and Transfusion Medicine, University Clinic Bonn, Germany
M. Marinova

¹Institute of Experimental Haematology and Transfusion Medicine, University Clinic Bonn, Germany
M. Hass

¹Institute of Experimental Haematology and Transfusion Medicine, University Clinic Bonn, Germany
J. Oldenburg

¹Institute of Experimental Haematology and Transfusion Medicine, University Clinic Bonn, Germany

Publikationsdatum:
04. Januar 2018 (online)

References
1 Rost S, Fregin A, Ivaskevicius V. et al. Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2. Nature 2004; 427 6974 537-541.

Crossref PubMed Suche in Google Scholar
Download RIS citation
2 Oldenburg J, Bevans CG, Müller CR, Watzka M. Vitamin K epoxide reductase complex subunit 1 (VKORC1): the key protein of the vitamin K cycle. Antioxid Redox Signal 2006; 8 3–4 347-353.

Crossref PubMed Suche in Google Scholar
Download RIS citation